Featured News
More News
Karl Deisseroth receives Transformative Research Award
The Stanford scientists will receive $32 million over five years to fund explorations of cancer, the brain, the aging process, chromosomes and the development of cells.
Chemist Carolyn Bertozzi on bridging chemistry and medicine
As chemist Carolyn Bertozzi takes on a new role as Baker Family Co-Director, Stanford ChEM-H, she talks about bridging gaps between chemistry research and medical practice and preparing graduate students for the future.
New Chan Zuckerberg Biohub awards encourage Stanford, UCSF and UC Berkeley research collaborations
Seventeen Stanford faculty are part of new Bay Area-wide collaborative research teams funded by the Chan Zuckerberg Biohub, co-directed by Stephen Quake.
We are bombarded by thousands of diverse species and chemicals
Stanford scientists have measured the human “exposome,” or the particulates, chemicals and microbes that individually swaddle us all, in unprecedented detail.
Bill Gates on How Blood Will Soon Tell Us Everything
Bill Gates, cofounder of Microsoft nominates Stephen Quake, professor of bioengineering and applied physics at Stanford University and copresident of the Chan Zuckerberg Biohub.
A decade-long study finds that roughly 1 in 10 people carry genetic variants that may blunt the blood sugar-lowering effects of widely used diabetes medications — raising new questions about precision medicine in diabetes care. Read more...